$0.11 Earnings Per Share Expected for NextGen Healthcare, Inc. (NASDAQ:NXGN) This Quarter

Equities analysts expect that NextGen Healthcare, Inc. (NASDAQ:NXGNGet Rating) will report $0.11 earnings per share (EPS) for the current quarter, Zacks reports. Three analysts have issued estimates for NextGen Healthcare’s earnings. The lowest EPS estimate is $0.05 and the highest is $0.17. NextGen Healthcare posted earnings of $0.18 per share during the same quarter last year, which would indicate a negative year over year growth rate of 38.9%. The firm is expected to issue its next earnings report on Monday, January 1st.

According to Zacks, analysts expect that NextGen Healthcare will report full-year earnings of $0.61 per share for the current year, with EPS estimates ranging from $0.60 to $0.63. For the next year, analysts anticipate that the business will post earnings of $0.66 per share, with EPS estimates ranging from $0.64 to $0.69. Zacks’ EPS calculations are a mean average based on a survey of sell-side research firms that cover NextGen Healthcare.

NextGen Healthcare (NASDAQ:NXGNGet Rating) last released its earnings results on Tuesday, May 17th. The company reported $0.19 EPS for the quarter, hitting the consensus estimate of $0.19. NextGen Healthcare had a return on equity of 10.11% and a net margin of 0.27%. The firm had revenue of $151.26 million during the quarter, compared to analysts’ expectations of $150.07 million. During the same period in the previous year, the firm posted $0.13 EPS. NextGen Healthcare’s revenue for the quarter was up 4.9% on a year-over-year basis.

Several research analysts have recently issued reports on the company. Guggenheim raised NextGen Healthcare from a “neutral” rating to a “buy” rating and set a $26.00 price objective for the company in a research report on Friday, May 6th. StockNews.com assumed coverage on NextGen Healthcare in a research report on Thursday, March 31st. They set a “strong-buy” rating for the company. Finally, Zacks Investment Research cut NextGen Healthcare from a “hold” rating to a “sell” rating and set a $21.00 price objective for the company. in a research report on Thursday, May 5th. One research analyst has rated the stock with a sell rating, two have given a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, NextGen Healthcare presently has an average rating of “Buy” and a consensus target price of $22.17.

NASDAQ:NXGN opened at $18.43 on Tuesday. The stock has a 50-day simple moving average of $19.94 and a 200-day simple moving average of $18.79. The stock has a market cap of $1.24 billion, a P/E ratio of 614.54 and a beta of 1.17. NextGen Healthcare has a 1 year low of $13.64 and a 1 year high of $21.87.

In other NextGen Healthcare news, CTO David A. Metcalfe sold 33,838 shares of the company’s stock in a transaction that occurred on Tuesday, May 3rd. The stock was sold at an average price of $20.00, for a total transaction of $676,760.00. Following the completion of the sale, the chief technology officer now directly owns 155,013 shares of the company’s stock, valued at approximately $3,100,260. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Craig A. Barbarosh sold 3,500 shares of the company’s stock in a transaction that occurred on Friday, April 1st. The shares were sold at an average price of $21.27, for a total value of $74,445.00. Following the sale, the director now directly owns 74,683 shares of the company’s stock, valued at $1,588,507.41. The disclosure for this sale can be found here. Insiders sold a total of 144,551 shares of company stock valued at $2,896,091 over the last three months. Company insiders own 18.70% of the company’s stock.

A number of institutional investors and hedge funds have recently bought and sold shares of NXGN. Royal Bank of Canada raised its stake in NextGen Healthcare by 214.9% during the 2nd quarter. Royal Bank of Canada now owns 5,617 shares of the company’s stock valued at $93,000 after acquiring an additional 3,833 shares during the last quarter. Morgan Stanley raised its stake in shares of NextGen Healthcare by 12.2% during the 2nd quarter. Morgan Stanley now owns 459,384 shares of the company’s stock worth $7,622,000 after buying an additional 49,980 shares in the last quarter. BlackRock Inc. raised its stake in shares of NextGen Healthcare by 1.2% during the 3rd quarter. BlackRock Inc. now owns 9,444,335 shares of the company’s stock worth $133,167,000 after buying an additional 112,354 shares in the last quarter. Barclays PLC raised its stake in shares of NextGen Healthcare by 176.1% during the 3rd quarter. Barclays PLC now owns 94,721 shares of the company’s stock worth $1,335,000 after buying an additional 60,410 shares in the last quarter. Finally, Goldman Sachs Group Inc. raised its stake in shares of NextGen Healthcare by 106.3% during the 3rd quarter. Goldman Sachs Group Inc. now owns 473,397 shares of the company’s stock worth $6,675,000 after buying an additional 243,886 shares in the last quarter. 71.15% of the stock is owned by hedge funds and other institutional investors.

NextGen Healthcare Company Profile (Get Rating)

NextGen Healthcare, Inc provides software and services for ambulatory healthcare services in the United States. The company offers patient engagement solutions, comprising of NextGen PxP Portal, NextGen Patient Self Scheduling, NextGen Pay, and NextGen Virtual Visits; clinical care solutions, including NextGen Enterprise HER, NextGen Mobile, NextGen Office, NextGen Behavioral Health Suite, NextGen Orthopedic Suite, and QSIDental Web and QSIDental PM; and financial management solutions, such as NextGen Enterprise PM and NextGen Clearinghouse Solutions.

Featured Articles

Get a free copy of the Zacks research report on NextGen Healthcare (NXGN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for NextGen Healthcare (NASDAQ:NXGN)

Receive News & Ratings for NextGen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextGen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.